NAD+ and Mounjaro Together — Synergy or Safety Risk?

Last reviewed: July 16, 2026

Last updated: July 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide (Mounjaro) works by activating GLP-1 and GIP receptors to regulate appetite and blood sugar, affecting roughly 70% of patients who attempt weight loss with lifestyle changes alone. NAD+ precursors like NMN and NR support cellular energy production and mitochondrial function through completely different mechanisms. The question many patients ask: can these two therapies work together safely, or do they create unwanted interactions?

How Tirzepatide and NAD+ Function in Different Metabolic Pathways

Tirzepatide activates GLP-1 and GIP signaling, which directly influences appetite centers in the hypothalamus and slows gastric emptying. These receptor pathways also improve insulin sensitivity and reduce hepatic glucose production. NAD+ (nicotinamide adenine dinucleotide), by contrast, fuels ATP production inside mitochondria and activates sirtuins—proteins linked to cellular repair and longevity. The two compounds operate on largely separate biochemical highways.

PlexusDx Precision Peptide Genetic Test identifies individual variations in GLP1R (rs6923761) and GIPR (rs1800437) pathways, revealing how efficiently your body responds to tirzepatide therapy. NAD+ responsiveness depends on NAD+ synthase activity and mitochondrial capacity, which are not currently measured by standard GLP-1 genetic profiling. Understanding both your peptide genetics and baseline metabolic health provides a clearer picture of whether dual therapy makes sense for you.

Current Evidence on Combining GLP-1 Agonists with NAD+ Supplements

Published clinical trials on tirzepatide have not formally evaluated concurrent NAD+ supplementation, so no head-to-head safety data exists. However, preclinical and observational evidence suggests no direct pharmacological conflict between GLP-1 signaling and NAD+ pathways. A 2023 metabolism review noted that GLP-1 agonists may actually improve mitochondrial efficiency over time, which could theoretically complement NAD+ boosting strategies.

One concern worth monitoring: rapid weight loss from tirzepatide can increase metabolic stress and free radical production. If NAD+ supplementation supports antioxidant defenses during this period, it may reduce oxidative load on tissues. Conversely, some users report GI side effects (nausea, constipation) from tirzepatide; adding supplements increases total oral intake and may compound digestive strain. Your prescribing provider should know about all supplements you take to watch for unexpected interactions or absorption issues.

Practical Considerations When Stacking Tirzepatide with NAD+ Boosters

Timing matters when combining injected tirzepatide with oral NAD+ precursors. Tirzepatide is administered subcutaneously once weekly, achieving peak levels in 8–72 hours depending on dose. NAD+ supplements (NMN, NR) are taken orally and absorbed through the intestinal epithelium; slowed gastric emptying from tirzepatide may reduce NAD+ bioavailability. Separating doses by several hours and taking NAD+ supplements with food may optimize absorption, though individual variation is significant.

PlexusDx tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) across all commitment tiers—your dose may need to go up as you progress through therapy, but your price won't. If you choose to add NAD+ supplementation, budget for that cost separately, as it is not part of PlexusDx services. Monitor your energy levels, muscle recovery, and GI tolerance closely during the first 4–8 weeks; any unexpected fatigue or worsening nausea warrants a conversation with your healthcare provider.

When to Request Genetic Testing to Personalize Your Approach

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with FTO variants associated with higher baseline metabolic stress may theoretically benefit more from concurrent NAD+ support, since mitochondrial efficiency becomes a limiting factor. Conversely, those with strong GLP1R responsiveness may achieve weight loss goals with tirzepatide alone, making NAD+ supplementation optional. Genetic testing does not directly assess NAD+ metabolism, but it contextualizes your overall metabolic capacity and helps avoid unnecessary polypharmacy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take NAD+ supplements while using tirzepatide injections?

No published adverse interactions exist between tirzepatide and NAD+ precursors. However, tirzepatide slows gastric emptying, which may reduce NAD+ absorption. Discuss all supplements with your provider before combining them to monitor for unexpected GI effects or individual tolerance issues.

Can NAD+ boosters improve the weight loss results from tirzepatide?

NAD+ supports mitochondrial energy production and cellular repair, which may theoretically enhance recovery during rapid weight loss. No clinical trial has directly tested this combination, so benefits remain speculative. The primary weight loss driver is tirzepatide's GLP-1 and GIP signaling; NAD+ would be a complementary strategy, not a replacement.

How much does tirzepatide cost at PlexusDx, and can I add NAD+ testing?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with no flat per-compound pricing increases. NAD+ supplementation is not part of PlexusDx services, so you would purchase it separately. The Precision Peptide Genetic Test costs $99 and can be added after your first month to optimize your therapy plan.

What side effects might occur if I combine tirzepatide with NAD+ supplements?

The most likely issue is compounded GI upset—tirzepatide already causes nausea and constipation in some patients, and additional oral supplements may worsen these effects. Fatigue or headache during initial NAD+ supplementation is also possible. Start one therapy at a time and allow 2–4 weeks for your body to adjust before adding the second.

Will the Precision Peptide Genetic Test tell me if NAD+ therapy is right for me?

PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R that affect your peptide metabolism and metabolic stress capacity. While it does not directly assess NAD+ pathway genes, it clarifies your baseline mitochondrial burden and whether metabolic support strategies might benefit you alongside tirzepatide therapy.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.